Börse:
3,477€
0,97%
Echtzeit-Aktienkurs Oramed Pharmaceuticals
Bid:
3,441€
Ask:
3,514€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 60,40 Mio. EUR (17,37 Mio. x 3,477€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 71,51 | 19,35 | 24,66 |
| KGV | - | - | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Oramed Pharmaceuticals Aktie
Börsenkurse Oramed Pharmaceuticals
| Lang & Schwarz | 3,000€ | 16667 | 3,740€ | 13369 | 3,370€ | -4,30% |
| Euro Indikation | 3,441€ | 0 | 3,514€ | 0 | 3,477€ | 0,97% |
| Börse Stuttgart | 3,441€ | 2000 | 3,514€ | 2000 | 3,477€ | 4,62% |
| Tradegate | 3,441€ | 880 | 3,514€ | 860 | 3,477€ | -1,26% |
| Dollar Indikation | 3,739$ | 0 | 4,000$ | 0 | 3,870$ | -2,28% |
Fundamentaldaten der Oramed Pharmaceuticals Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 2,45 Mio. | -12,73 Mio. | -12,73 Mio. | -0,86 | 0,00% | - | 24,66 |
| 2017 | 2,46 Mio. | -10,08 Mio. | -10,48 Mio. | -0,79 | 0,00% | - | 19,35 |
| 2016 | 0,64 Mio. | -9,63 Mio. | -10,96 Mio. | -0,87 | 0,00% | - | 71,51 |
Profil der Oramed Pharmaceuticals Aktie
Oramed Pharmaceuticals, Inc. engages in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen